Home
United States (EN)Change

Global Navigation

  • On-demand Learning
  • Tailored Learning
  • Upcoming Events
  • Virtual Reality
  • COVID-19 Community Hub
  • News

Browse on-demand learning specialties

  • Animal Health
  • Bariatric
  • Bleeding Management
  • Breast
  • Cardiac Electrophysiology
  • Colon & Rectal
  • Craniomaxillofacial
  • Ear, Nose & Throat
  • Foot & Ankle
  • Gynecology
  • Hand & Wrist
  • Hepato-Pancreato-Biliary (HPB)
  • Hernia
  • Infection Risk Management
  • Interventional Solutions
  • Joint Arthroplasty
  • Neuro-Intervention
  • Nurse Education
  • Outpatient Education
  • Physician Assistant
  • Professional Resources
  • Spine
  • Sports Medicine
  • Thoracic
  • Trauma
  • Upper GI & Abdominal
  • Vision
  • Wound Closure
View All
  • Home
  • News
  • Nearly 40,000 HCPs Tune in for The New Normal in Elective Surgery: Johnson & Johnson Institute Supports Webinar on AIS Channel for Healthcare Professionals

Global Navigation {Mobile}

  • On-demand Learning
  • Tailored Learning
  • Upcoming Events
  • Virtual Reality
  • COVID-19 Community Hub
  • News
COVID-19 New Normal & Key Articles of Interest
Nearly 40,000 HCPs Tune in for The New Normal in Elective Surgery: Johnson & Johnson Institute Supports Webinar on AIS Channel for Healthcare Professionals

For months now, COVID-19 has put the world into lockdown and turned healthcare systems into emergency-only operations. As hospitals begin to emerge from this unusual situation, they are thinking through the best course of action when it comes to resuming elective procedures. It is a complex process that will require unparalleled coordination and partnership. 

By Johnson & Johnson Institute,
May 15 2020
6
minute read
Nearly 40,000 HCPs Tune in for The New Normal in Elective Surgery: Johnson & Johnson Institute Supports Webinar on AIS Channel for Healthcare Professionals

As part of our enterprise response to COVID-19, the Johnson & Johnson Institute has supported a number of AIS educational programs focused on advancing patient care in the COVID-19 environment. The most recent program, titled “The New Normal in Elective Surgery” featured healthcare experts from around the globe sharing advice and lessons around hospital re-openings. The webinar attracted more than 39,000 healthcare professionals including surgeons physicians, nurses, and hospital administrators from 148 countries.

Speakers included:

  • Ashley McEvoy, Executive Vice President, Worldwide Chairman, Medical Devices, Johnson & Johnson
  • Dr. Marc Boom, CEO of the Houston Methodist Hospital, USA
  • Dr. Manish Chand, Consultant Colorectal & Endometriosis Surgeon, University College London, United Kingdom
  • Linda Groah, CEO of AORN, USA
  • Mr. Rod Menchaca, CEO of Advances in Surgery, Barcelona, Spain 
  • Dr. Jean-Blaise Wasserfallen, Vice-medical director of University Hospital Lausanne, Switzerland
  • Dr. Steven Wexner, Cleveland Clinic Florida, Director of the Digestive Disease Center, USA

Register for free to watch the entire webinar here, or watch individual sessions from participants including Ashley McEvoy here.  

The discussion focused on the immediate steps and logistical hurdles that will come with re-opening elective surgeries, including determining which procedures to prioritize, retraining staff, and managing employee burnout. Groah shared a five-phased roadmap from AORN, saying that “if hospitals follow these guidelines, patients can be assured that best practices are adhered to, and they, therefore, should have the best possible outcomes.”

McEvoy shared how Johnson & Johnson is helping hospitals adapt to the new normal and prepare to restart elective surgeries: “We are partnering with healthcare professionals, health systems and patients to ensure people everywhere receive the treatment they need as we collectively establish the new normal in elective surgery. Our team is leveraging technology in new ways to offer virtual training and to support procedures in hospitals, ambulatory surgery centers, and other sites of care. We are looking at how we can facilitate pre-operative and post-operative care using digital solutions to change the patient experience both during and beyond COVID-19 to make the care continuum more seamless and patient-friendly.” 
Panelists also discussed the longer-term implications of the current healthcare disruption, including a shift to telehealth and greater collaboration between specialties. 

“As we emerge from this crisis, we need to have a collaborative plan that includes all stakeholders,” said Dr. Chand. “Perhaps coming out of this, we’ll have a health system that’s more efficient for patients and healthcare professionals.” 

This webinar is part of an expanded collaboration between Johnson & Johnson Institute and AIS to connect HCPs to a virtual COVID-19 Resource Center. HCPs can access important information from multiple public sources, updated in real-time, as well as free online courses and training programs to help everyone perform their work in the safest and most effective way possible. 

Latest News

COVID-19 New Normal & Key Articles of Interest
An image from the "New Variant of SARS-CoV-2 in UK Causes Surge of COVID-19" news article on the JnJInstitute.com website.
New Variant of SARS-CoV-2 in UK Causes Surge of COVID-19
Jan 11, 2021
COVID-19 New Normal & Key Articles of Interest
An image from the "Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data" news article on the JnJInstitute.com website.
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data
Jan 04, 2021
COVID-19 New Normal & Key Articles of Interest
An image from the "Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019" news article on the JnJInstitute.com website.
Digital Health Surveillance Strategies for Management of Coronavirus Disease 2019
Dec 15, 2020
COVID-19 New Normal & Key Articles of Interest
An image from the "Therapeutically Administered Ribonucleoside Analogue MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets" news article on the JnJInstitute.com website.
Therapeutically Administered Ribonucleoside Analogue MK-4482/EIDD-2801 Blocks SARS-CoV-2 Transmission in Ferrets
Dec 06, 2020
All

Quick Links

  • On-demand Learning
  • Tailored Learning
  • Upcoming Events
  • News
  • About Us
  • Virtual Reality

Follow US

Find us

  • Our Locations

More from johnson & johnson

Johnson & Johnson

Johnson & Johnson Medical Devices

Johnson & Johnson: Our Story

More than 130 Years of Healthcare Innovation

Please see our Privacy Policy and Cookie Policy. Use of this site constitutes your consent to the application of such laws and regulations and to our Privacy Policy and Cookie Policy. Your use of the information on this site is subject to the terms of our Terms of Use. Contact Us with any questions or search this site for more information.

This website is published by Johnson & Johnson Services, Inc., which is solely responsible for its content. This website is intended for visitors in North America, EMEA, Latin America and Asia Pacific. Third party trademarks used herein are trademarks of their respective owners. Portions of this website are intended for visitors from certain geographical regions only and will be indicated as such.

The materials on this website are intended to provide information about products of the Johnson & Johnson Medical Devices Companies. Each product has its own labeling, which may include specific limitations relevant to the use of the product and which may vary from country to country. Please remember to check the local labeling of each product you plan to use to be aware of these limitations. If you have any questions on the use of these products, please contact your sales consultant.

093430-180612

jnj logo
 
TERMS AND CONDITIONS

All contents © Johnson & Johnson Services, Inc. 2020. All Rights Reserved.

jnj logo